Effect of Novel Inflammatory Biomarkers on Adverse Outcomes in Patients with Interstitial Lung Disease and Pneumonia: A Multicenter Retrospective Cohort Study
CONCLUSION: To some extent, SII levels exhibit correlations with the clinical manifestations in patients grappling with interstitial lung disease complicated by pneumonia. Notably, a high SII level is an independent predictor for an unfavorable prognosis in these patients. Nevertheless, these findings warrant further validation through prospective cohort studies.PMID:38698751 | DOI:10.2174/0113862073286907240308095907
Source: Combinatorial Chemistry and High Throughput Screening - Category: Chemistry Authors: Wenmei Bai Yide Wang Fengsen Li Source Type: research
More News: Cardiology | Chemistry | Heart | Interstitial Lung Disease | Pneumonia | Statistics | Study